Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies

被引:29
|
作者
Vianello, M [1 ]
Tavolato, B [1 ]
Armani, M [1 ]
Giometto, B [1 ]
机构
[1] Univ Padua, Dept Neurol & Psychiat Sci, Clin 2, I-35137 Padua, Italy
关键词
cerebellar ataxia; GAD antibodies; autoimmunity;
D O I
10.1080/14734220309432
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent reports describe the detection of high titres of antibodies to glutamic acid decarboxylase (GAD-Ab) in the serum and cerebrospinal fluid. (CSF) of patients with cerebellar ataxia. Most of these cases are females with Polyglandular Autoimmune Disorder who develop a chronic cerebellar syndrome. The CSF profile is in keeping with an autoimmune disorder and intrathecal GAD-Ab synthesis has been demonstrated. The ataxia could reverse after immunomodulatory treatments suggesting a possible pathogenetic role for GAD-Ab.
引用
收藏
页码:77 / 79
页数:3
相关论文
共 50 条
  • [21] Clinical features and immunotherapy outcomes of anti-glutamic acid decarboxylase 65 antibody-associated neurological disorders
    Li Chengyu
    Shi Weixiong
    Chen Chao
    Liu Songyan
    Sang Lin
    Zheng Zhong
    Pan Hua
    Jian Fan
    Chen Na
    Cui Tao
    Wu Jianwei
    Ren Haitao
    Guan Hongzhi
    Shao Xiaoqiu
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 345
  • [22] Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies
    Martins, Ana I.
    Carvalho, Joao N.
    Amorim, Ana M.
    Geraldo, Argemiro
    Eggenberger, Eric
    Lemos, Joao
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2018, 38 (01) : 32 - 35
  • [23] The potential of anti-glutamic acid decarboxylase antibodies to support a diagnosis of autoimmune diabetes mellitus
    Liepert, Maryah
    Alhaqqan, Shamayel
    Husain, Alaa
    Lochnan, Heather
    Booth, Ronald A.
    Shaw, Julie
    Sun, Cathy J.
    CLINICAL BIOCHEMISTRY, 2025, 135
  • [24] Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients
    Andrade Lima Gabbay, M.
    Sato, M. N.
    Duarte, A. J. S.
    Dib, S. A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 168 (01) : 60 - 67
  • [25] Anti-Glutamic Acid Decarboxylase Encephalitis Presenting With Choreo-Dystonic Movements and Coexisting Electrographic Seizures
    Kauppila, Linda Azevedo
    Coelho, Miguel
    Franco, Ana Catarina
    Teodoro, Tiago
    Peralta, Ana Rita
    Bentes, Carla
    Falcao, Filipa
    Albuquerque, Luisa
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (06): : 483 - 485
  • [26] Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia
    Takenoshita, H
    Shizuka-Ikeda, M
    Mitoma, H
    Song, SY
    Harigaya, Y
    Igeta, Y
    Yaguchi, M
    Ishida, K
    Shoji, M
    Tanaka, M
    Mizusawa, H
    Okamoto, K
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03) : 386 - 389
  • [27] Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: A multicenter study
    Wild, T
    Scherbaum, WA
    Gleichmann, H
    Landt, M
    Santiago, J
    Endl, J
    Landgraf, R
    Cavallo, MG
    Ganz, M
    Pozzilli, P
    HORMONE AND METABOLIC RESEARCH, 1997, 29 (08) : 403 - 406
  • [28] Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase
    Hayakawa, N
    Premawardhana, LDKE
    Powell, M
    Masuda, M
    Arnold, C
    Sanders, J
    Evans, M
    Chen, S
    Jaume, JC
    Baekkeskov, S
    Smith, BR
    Furmaniak, J
    AUTOIMMUNITY, 2002, 35 (05) : 343 - 355
  • [29] The neurological syndromes associated with glutamic acid decarboxylase antibodies
    Fidel Baizabal-Carvallo, Jose
    JOURNAL OF AUTOIMMUNITY, 2019, 101 : 35 - 47
  • [30] Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity
    Errichiello, Luca
    Striano, Salvatore
    Zara, Federico
    Striano, Pasquale
    NEUROLOGICAL SCIENCES, 2011, 32 (04) : 547 - 550